Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Barrier-Breaking Drug May Lead to Spinal Cord Injury Treatments
NIH-funded scientists take first step towards developing promising new drug.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.
New Drug for Common Liver Disease Improves Liver Health
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the NIH.
'Rewriting' the Way to Make Natural Drug Compounds
Using an organism's own pathway to synthesize potential therapeutics.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.

Novel Histamine Receptor Family Antagonists by Fragment Screening and Molecular Modelling
Mark Slack, Group Leader Cellular Assays, Evotec, speaking at MedChem Europe

The Development of Synthetic Approaches that Allow the Systematic Exploration of Chemical Space
Adam Nelson, Professor, University of Leeds, speaking at MedChem Europe

Next-Generation Kinase Inhibitors following a Retro-Design Approach
Gerhard Mueller, Chief Scientific Officer, Proteros Fragments, speaking at MedChem Europe

Beyond Growing and Linking - Impact of Fragments on the Discovery of Kinase Inhibitors
Andreas Kuglstatter, Research Scientist II, Hoffmann-La Roche, speaking at MedChem Europe

A Novel Platform Technology Sheds Light on the Molecular Mechanisms of Liver Toxicity of Two Parkinson Drugs
Friedrich Kroll, Head of Medicinal Chemistry, Caprotec, speaking at MedChem Europe

The Impact of Fragment Optimization on Lead Quality
György Keseru, Head of Discovery Chemistry, Gedeon Richter, speaking at MedChem Europe

Chemogenomic Strategies to Expand the Bioactive Chemical Space
Edgar Jacoby, Group Leader, Novartis, speaking at MedChem Europe

Dynamic Combinatorial Library – an Integrated Approach for Direct Lead Discovery Using Chemical Fragments
Beining Chen, Senior Lecturer, University of Sheffield, speaking at MedChem Europe

Dynamic Combinatorial Library – an Integrated Approach for Direct Lead Discovery Using Chemical Fragments
Beining Chen, Senior Lecturer, University of Sheffield, speaking at MedChem Europe

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 134
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn